Using neurons created from iPS cells derived from people with ALS, researchers develop a new drug which appears to halt the impact of the genetic mutations in some forms of ALS and dementia.
Researchers have mapped the reorganization of genetic material that takes place when a stem cell matures into a nerve cell.
A new blood test can distinguish the severity of a person's depression and their risk for developing severe depression at a later point. The test can also determine if a person is at risk for developing bipolar disorder. Researchers say the blood test can also assist in tailoring individual options for therapeutic interventions.
Axon myelination is significantly disrupted in patients with Alzheimer's disease. Researchers also found brain cells of men and women vary significantly in how their genes respond to the neurodegenerative disease.
Researchers report a chemical modifications that add methyl groups to RNA could help strengthen memory formation.
Researchers report the expansion of the human neocortex is likely due to a single base pair genetic substitution.
A new study reviews the different aging processes that affect the brain and liver of rats. The findings also allowed the researchers to better understand general overall aging processes.
A new study points to a potential new target to treat neurodegenerative diseases.
Researchers report altering the RNA helicases in roundworms doubles their lifespans. They believe a similar technique could also work on human cells.
A drug used to treat feline infectious peritonitis, an often fatal coronavirus infection in cats, may hold the key for developing a treatment for human COVID-19.
Retroviruses may be a missing causal link in diseases like ALS, multiple sclerosis and schizophrenia.
IBM Watson helps researchers identify five new genes associated with amyotrophic lateral sclerosis.
